Mepolizumab Demonstrates Real-world Clinical Effectiveness in both Type 2 Biomarker High and Type 2 Biomarker Low Patients with Severe Asthma.
- Resource Type
- Article
- Authors
- Chupp, Geoffrey; Lee, Jason; Liu, Mark; Schleich, Florence; Heaney, Liam; Ribas, Christian Domingo; Carrillo-Díaz, Teresa; Aparicio, Marina Blanco; Moragón, Eva Martínez; Sanchez-Herrero, M Guadalupe; Gardiner, Frances; Alfonso-Cristancho, Rafael; Jakes, Rupert; Price, Robert; Howarth, Peter
- Source
- Journal of Allergy & Clinical Immunology; 2022 Supplement, Vol. 149 Issue 2, pAB318-AB318, 1p
- Subject
- Language
- ISSN
- 00916749